Aumolertinib + chemotherapy improves progression-free survival in NSCLC: Clinical trial

Updated on: September 30,2025

Aumolertinib + chemotherapy improves progression-free survival in NSCLC: Clinical trial

Updated on:September 30,2025

Modified CAR-T cells target widespread protein found in multiple types of cancer

Updated on: July 12,2025

Modified CAR-T cells target widespread protein found in multiple types of cancer

Updated on:July 12,2025

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC

Updated on: September 30,2025

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC

Updated on:September 30,2025

Geroscience: Rethinking how medicine can approach aging

Updated on: September 04,2025

Geroscience: Rethinking how medicine can approach aging

Updated on:September 04,2025

Mathematical model reveals surprising light levels in the womb, reshaping fetal vision understanding

Updated on: March 29,2025

Mathematical model reveals surprising light levels in the womb, reshaping fetal vision understanding

Updated on:March 29,2025

Drug combination shows promise for early treatment after myocardial infarction

Updated on: July 10,2025

Drug combination shows promise for early treatment after myocardial infarction

Updated on:July 10,2025

Medicine Net Update 2025/07/10

On Jul 03, 2025, Norvatis announced results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA).

Updated on: July 16,2025

Medicine Net Update 2025/07/10

On Jul 03, 2025, Norvatis announced results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA).

Updated on:July 16,2025

RNA molecule identified as possible driver of gastric cancer

Updated on: April 21,2025

RNA molecule identified as possible driver of gastric cancer

Updated on:April 21,2025

Antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission

byWalter and Eliza Hall Institute of Medical ResearchThese images show the malaria parasites before and after treatment. Without MK-7602, parasites (purple) invade red blood cells (blue) after two day

Updated on: December 27,2025

Antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission

byWalter and Eliza Hall Institute of Medical ResearchThese images show the malaria parasites before and after treatment. Without MK-7602, parasites (purple) invade red blood cells (blue) after two day

Updated on:December 27,2025

Inducing prolonged torpor-like state in mice slows epigenetic changes that accompany aging

Updated on: April 18,2025

Inducing prolonged torpor-like state in mice slows epigenetic changes that accompany aging

Updated on:April 18,2025